The Chinese herb Tripterygium wilfordii Hook F for the treatment of systemic sclerosis-associated interstitial lung disease: data from a Chinese EUSTAR Center

被引：0
|
作者：
Luwei Yang
Qian Wang
Yong Hou
Jiuliang Zhao
Mengtao Li
Dong Xu
Xiaofeng Zeng
机构：
[1] Chinese Academy of Medical Sciences & Peking Union Medical College,Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital
来源：
Clinical Rheumatology | 2020年 / 39卷
关键词：
Cyclophosphamide; Interstitial lung disease; Systemic sclerosis; Hook F;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：813 / 821
页数：8
相关论文
共 50 条
  • [41] Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease
    Koutroumpas, Athanasios
    Ziogas, Athanasios
    Alexiou, Ioannis
    Barouta, Georgia
    Sakkas, Lazaros I.
    CLINICAL RHEUMATOLOGY, 2010, 29 (10) : 1167 - 1168
  • [42] Course of Progressive Lung Fibrosis in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in the EUSTAR Database
    Hoffmann-Vold, Anna-Maria
    Allanore, Yannick
    Alves, Margarida
    Graf, Nicole
    Airo, Paolo
    Ananyeva, Lidia P.
    Czirjak, Laszlo
    Guiducci, Serena
    Hachulla, Eric
    Li, Mengtao
    Mihai, Carina
    Riemekasten, Gabriela
    Sfikakis, Petros
    Valentini, Gabriele
    Kowal-Bielecka, Otylia
    Distler, Oliver
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] Responses to exercise in systemic sclerosis-associated interstitial lung disease
    Donnelly, Ronan P.
    Smyth, Anita E.
    Mullan, Charles
    Riley, Marshall S.
    Nicholls, D. Paul
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2023, 43 (04) : 253 - 262
  • [44] Systemic sclerosis-associated interstitial lung disease treated with tocilizumab
    Dauny, Vincent
    Borie, Raphael
    Forien, Marine
    Ghanem, Mada
    Palazzo, Elisabeth
    Jelin, Germain
    Dieude, Philippe
    Ottaviani, Sebastien
    INTERNAL MEDICINE JOURNAL, 2021, 51 (06) : 999 - 1000
  • [45] Molecular Insights Into Systemic Sclerosis-Associated Interstitial Lung Disease
    Silver, Richard M.
    Feghali-Bostwick, Carol A.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (03) : 485 - 487
  • [46] Pleuroparenchymal fibroelastosis in systemic sclerosis-associated interstitial lung disease
    Sari, Alper
    Onder, Omer
    Armagan, Berkan
    Bolek, Ertugrul Cagri
    Farisogullari, Bayram
    Bilgin, Emre
    Yardimci, Gozde Kubra
    Ariyurek, Macit
    Akdogan, Ali
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (01) : 83 - 88
  • [47] Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region (vol 6, pg 2178, 2023)
    Lescoat, Alain
    RHEUMATOLOGY, 2023, 62 (09) : 3219 - 3220
  • [48] Prediction and Frequency of Progressive Lung Fibrosis in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease in the World's Largest Database of Patients with Systemic Sclerosis (EUSTAR)
    Hoffmann-Vold, A.
    Allanore, Y.
    Alves, M.
    Graf, N.
    Airo, P.
    Ananyeva, L. P.
    Czirjak, L.
    Guiducci, S.
    Hachulla, E.
    Li, M.
    Mihai, C.
    Riemekasten, G.
    Sfikakis, P.
    Valentini, G.
    Kowal-Bielecka, O.
    Distler, O.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [49] Rituximab in the treatment of systemic sclerosis-associated interstitial lung disease: Comment on the article by Yoo
    Daoussis, Dimitrios
    Andonopoulos, Andrew P.
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (06) : 841 - 842
  • [50] Efficacy of Mycophenolate Associated with Methotrexate as a Maintenance Treatment for Systemic Sclerosis-Associated Interstitial Lung Disease
    Antonio Gonzalez-Nieto, Jose
    Javier Martin-Suarez, Ignacio
    Luis Gil-Munoz, Francisco
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (11): : 575 - 575
12345